Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Novel daratumumab-based regimen slows multiple myeloma progression

Prof Antonio Palumbo - University of Torina, Turin, Italy
Novel daratumumab-based regimen slows multiple myeloma progression ( Prof Antonio Palumbo - University of Torina, Turin, Italy )
5 Jun 2016

Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma

Dr Julie Park - Seattle Children's Hospital, Seattle, USA
Double stem-cell transplant improves outcomes for children with high-risk neuroblastoma ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )
5 Jun 2016

Latest in hepatocellular carcinoma treatments

Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Latest in hepatocellular carcinoma treatments ( Dr Ghassan Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA )
4 Jun 2016

Intraperitoneal chemotherapy slows ovarian cancer progression

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada
Intraperitoneal chemotherapy slows ovarian cancer progression ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )
4 Jun 2016

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016

Innovative direct-to-patient outreach may accelerate breast cancer research

Dr Nikhil Wagle - Dana Farber Cancer Institute, Boston, USA
Innovative direct-to-patient outreach may accelerate breast cancer research ( Dr Nikhil Wagle - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2016

Liquid biopsy may help guide treatment decisions for advanced solid tumours

Prof Philip Mack - University of California Davis, Davis, USA
Liquid biopsy may help guide treatment decisions for advanced solid tumours ( Prof Philip Mack - University of California Davis, Davis, USA )
4 Jun 2016

ASCO 2016: Expert discussion on the latest on multiple myeloma

Dr Sagar Lonial and Dr Paul Richardson
ASCO 2016: Expert discussion on the latest on multiple myeloma ( Dr Sagar Lonial and Dr Paul Richardson )
3 Jun 2016

Hypo-fractionation of prostate cancer radiotherapy

Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada
Hypo-fractionation of prostate cancer radiotherapy ( Dr Charles Catton - Princess Margaret Cancer Centre, Toronto, Canada )
3 Jun 2016

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma

Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK
Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )
3 Jun 2016

Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada
Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )
3 Jun 2016

Temozolomide after radiotherapy improves glioma survival

Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands
Temozolomide after radiotherapy improves glioma survival ( Dr Martin Van Den Bent - Erasmus MC Cancer Center, Rotterdam, The Netherlands )
3 Jun 2016